We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Investing in Envista (NVST)? Don't Miss Assessing Its International Revenue Trends
Read MoreHide Full Article
Have you evaluated the performance of Envista's (NVST - Free Report) international operations during the quarter that concluded in June 2026? Considering the extensive worldwide presence of this maker of dental products, analyzing the patterns in international revenues is crucial for understanding its financial resilience and potential for growth.
In the current global economy, which is more interconnected than ever, a company's success in penetrating international markets is crucial for its financial health and growth journey. Investors must understand a company's dependence on overseas markets, as this offers a window into the company's earnings stability, its ability to benefit from varied economic cycles and its potential for long-term growth.
Participation in global economies acts as a defense against economic difficulties at home and a pathway to more rapidly developing economies. However, it also comes with the complexities of dealing with fluctuating currencies, geopolitical risks and different market dynamics.
In our recent assessment of NVST's quarterly performance, we discovered notable trends in its overseas revenue sections, which are typically modeled and scrutinized by Wall Street analysts.
The company's total revenue for the quarter amounted to $730.5 million, showing rise of 7.1%. We will now explore the breakdown of NVST's overseas revenue to assess the impact of its international operations.
A Closer Look at NVST's Revenue Streams Abroad
Emerging markets generated $166 million in revenues for the company in the last quarter, constituting 22.7% of the total. This represented a surprise of +3.43% compared to the $160.5 million projected by Wall Street analysts. Comparatively, in the previous quarter, Emerging markets accounted for $125 million (17.7%), and in the year-ago quarter, it contributed $150.4 million (22.1%) to the total revenue.
Other developed markets accounted for 4.7% of the company's total revenue during the quarter, translating to $34.5 million. Revenues from this region represented a surprise of +12.31%, with Wall Street analysts collectively expecting $30.72 million. When compared to the preceding quarter and the same quarter in the previous year, Other developed markets contributed $31.5 million (4.5%) and $29.7 million (4.4%) to the total revenue, respectively.
During the quarter, Western Europe contributed $165.3 million in revenue, making up 22.6% of the total revenue. When compared to the consensus estimate of $161.37 million, this meant a surprise of +2.44%. Looking back, Western Europe contributed $184.8 million, or 26.2%, in the previous quarter, and $154.1 million, or 22.6%, in the same quarter of the previous year.
Revenue Projections for Overseas Markets
The current fiscal quarter's total revenue for Envista, as projected by Wall Street analysts, is expected to reach $694.71 million, reflecting an increase of 3.7% from the same quarter last year. The breakdown of this revenue by foreign region is as follows: Emerging markets is anticipated to contribute 22.4% or $155.72 million, Other developed markets 4.6% or $31.71 million and Western Europe 20.7% or $143.44 million.
For the full year, a total revenue of $2.88 billion is expected for the company, reflecting an increase of 6% from the year before. The revenues from Emerging markets, Other developed markets and Western Europe are expected to make up 20.7%, 4.4%, and 23% of this total, corresponding to $596.25 million, $126.34 million, and $663.74 million, respectively.
In Conclusion
Envista's reliance on international markets for revenues offers both opportunities and risks. Hence, keeping an eye on its international revenue trends could significantly help forecast the company's prospects.
In an era of growing international ties and escalating geopolitical disputes, financial analysts on Wall Street pay keen attention to these developments to fine-tune their earnings estimations for businesses operating across borders. It's important to note, however, that a range of additional variables, like a company's local market status, also play a crucial role in shaping these forecasts.
Emphasizing a company's shifting earnings prospects is a key aspect of our approach at Zacks, especially since research has proven its substantial influence on a stock's price in the short run. This correlation is positively aligned, meaning that improved earnings projections tend to boost the stock's price.
With an impressive externally audited track record, our proprietary stock rating tool - the Zacks Rank - harnesses the power of earnings estimate revisions and serves as an effective indicator of a stock's near-term price performance.
Assessing Envista's Stock Price Movement in Recent Times
The stock has witnessed an increase of 8.7% over the past month versus the Zacks S&P 500 composite's an increase of 3.4%. In the same interval, the Zacks Medical sector, to which Envista belongs, has registered a decrease of 0.4%. Over the past three months, the company's shares saw an increase of 21.2%, while the S&P 500 increased by 6%. In comparison, the sector experienced an increase of 10.8% during this timeframe.
View the Zacks #1 Rank List
Image: Bigstock
Investing in Envista (NVST)? Don't Miss Assessing Its International Revenue Trends
Have you evaluated the performance of Envista's (NVST - Free Report) international operations during the quarter that concluded in June 2026? Considering the extensive worldwide presence of this maker of dental products, analyzing the patterns in international revenues is crucial for understanding its financial resilience and potential for growth.
In the current global economy, which is more interconnected than ever, a company's success in penetrating international markets is crucial for its financial health and growth journey. Investors must understand a company's dependence on overseas markets, as this offers a window into the company's earnings stability, its ability to benefit from varied economic cycles and its potential for long-term growth.
Participation in global economies acts as a defense against economic difficulties at home and a pathway to more rapidly developing economies. However, it also comes with the complexities of dealing with fluctuating currencies, geopolitical risks and different market dynamics.
In our recent assessment of NVST's quarterly performance, we discovered notable trends in its overseas revenue sections, which are typically modeled and scrutinized by Wall Street analysts.
The company's total revenue for the quarter amounted to $730.5 million, showing rise of 7.1%. We will now explore the breakdown of NVST's overseas revenue to assess the impact of its international operations.
A Closer Look at NVST's Revenue Streams Abroad
Emerging markets generated $166 million in revenues for the company in the last quarter, constituting 22.7% of the total. This represented a surprise of +3.43% compared to the $160.5 million projected by Wall Street analysts. Comparatively, in the previous quarter, Emerging markets accounted for $125 million (17.7%), and in the year-ago quarter, it contributed $150.4 million (22.1%) to the total revenue.
Other developed markets accounted for 4.7% of the company's total revenue during the quarter, translating to $34.5 million. Revenues from this region represented a surprise of +12.31%, with Wall Street analysts collectively expecting $30.72 million. When compared to the preceding quarter and the same quarter in the previous year, Other developed markets contributed $31.5 million (4.5%) and $29.7 million (4.4%) to the total revenue, respectively.
During the quarter, Western Europe contributed $165.3 million in revenue, making up 22.6% of the total revenue. When compared to the consensus estimate of $161.37 million, this meant a surprise of +2.44%. Looking back, Western Europe contributed $184.8 million, or 26.2%, in the previous quarter, and $154.1 million, or 22.6%, in the same quarter of the previous year.
Revenue Projections for Overseas Markets
The current fiscal quarter's total revenue for Envista, as projected by Wall Street analysts, is expected to reach $694.71 million, reflecting an increase of 3.7% from the same quarter last year. The breakdown of this revenue by foreign region is as follows: Emerging markets is anticipated to contribute 22.4% or $155.72 million, Other developed markets 4.6% or $31.71 million and Western Europe 20.7% or $143.44 million.For the full year, a total revenue of $2.88 billion is expected for the company, reflecting an increase of 6% from the year before. The revenues from Emerging markets, Other developed markets and Western Europe are expected to make up 20.7%, 4.4%, and 23% of this total, corresponding to $596.25 million, $126.34 million, and $663.74 million, respectively.
In Conclusion
Envista's reliance on international markets for revenues offers both opportunities and risks. Hence, keeping an eye on its international revenue trends could significantly help forecast the company's prospects.
In an era of growing international ties and escalating geopolitical disputes, financial analysts on Wall Street pay keen attention to these developments to fine-tune their earnings estimations for businesses operating across borders. It's important to note, however, that a range of additional variables, like a company's local market status, also play a crucial role in shaping these forecasts.
Emphasizing a company's shifting earnings prospects is a key aspect of our approach at Zacks, especially since research has proven its substantial influence on a stock's price in the short run. This correlation is positively aligned, meaning that improved earnings projections tend to boost the stock's price.
With an impressive externally audited track record, our proprietary stock rating tool - the Zacks Rank - harnesses the power of earnings estimate revisions and serves as an effective indicator of a stock's near-term price performance.
Envista currently has a Zacks Rank #1 (Strong Buy), indicating that it could outperform the broader market in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Assessing Envista's Stock Price Movement in Recent Times
The stock has witnessed an increase of 8.7% over the past month versus the Zacks S&P 500 composite's an increase of 3.4%. In the same interval, the Zacks Medical sector, to which Envista belongs, has registered a decrease of 0.4%. Over the past three months, the company's shares saw an increase of 21.2%, while the S&P 500 increased by 6%. In comparison, the sector experienced an increase of 10.8% during this timeframe.